Literature DB >> 9374561

Nosocomial respiratory syncytial virus infection in Canadian pediatric hospitals: a Pediatric Investigators Collaborative Network on Infections in Canada Study.

J M Langley1, J C LeBlanc, E E Wang, B J Law, N E MacDonald, I Mitchell, D Stephens, J McDonald, F D Boucher, S Dobson.   

Abstract

OBJECTIVE: To determine nosocomial transmission of respiratory syncytial virus (RSV) in Canadian pediatric hospitals, outcomes associated with nosocomial disease, and infection control practices.
DESIGN: A prospective cohort study in the 1992 to 1994 winter respiratory seasons.
SETTING: Nine Canadian pediatric university-affiliated hospitals. PARTICIPANTS: Hospitalized children with symptoms of lower respiratory tract infection (at least one of cough, wheezing, dyspnea, tachypnea, and apnea) and RSV antigen identified in a nasopharyngeal aspirate.
RESULTS: Of 1516 children, 91 (6%) had nosocomial RSV (NRSV), defined as symptoms of lower respiratory tract infection and RSV antigen beginning >72 hours after admission. The nosocomial ratio (NRSV/[com-munity-acquired RSV {CARSV})] + NRSV) varied by site from 2.8% to 13%. The median length of stay attributable to RSV for community-acquired illness was 5 days, but 10 days for nosocomial illness. Four children with NRSV (4. 4%) died within 2 weeks of infection, compared with 6 (0.42%) with CARSV (relative risk = 10.4, 95% confidence interval: 3.0, 36.4). All sites isolated RSV-positive patients in single rooms or cohorted them. In a multivariate model, no particular isolation policy was associated with decreased nosocomial ratio, but gowning to enter the room was associated with increased risk of RSV transmission (incidence rate ratio 2.81; confidence interval: 1.65, 4.77).
CONCLUSIONS: RSV transmission risk in Canadian pediatric hospitals is generally low. Although use of barrier methods varies, all sites cohort or isolate RSV-positive patients in single rooms. Children with risk factors for severe disease who acquire infection nosocomially have prolonged stays and excess mortality.

Entities:  

Mesh:

Year:  1997        PMID: 9374561     DOI: 10.1542/peds.100.6.943

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  17 in total

1.  Near patient testing for respiratory syncytial virus in paediatric accident and emergency: prospective pilot study.

Authors:  A Mackenzie; N Hallam; E Mitchell; T Beattie
Journal:  BMJ       Date:  1999-07-31

2.  Paediatric emergency department staff perceptions of infection control measures against severe acute respiratory syndrome.

Authors:  M J Parker; R D Goldman
Journal:  Emerg Med J       Date:  2006-05       Impact factor: 2.740

3.  A decade of respiratory syncytial virus epidemiology and prophylaxis: translating evidence into everyday clinical practice.

Authors:  Bosco A Paes; Ian Mitchell; Anna Banerji; Krista L Lanctôt; Joanne M Langley
Journal:  Can Respir J       Date:  2011 Mar-Apr       Impact factor: 2.409

4.  Use of palivizumab in children with congenital heart disease.

Authors: 
Journal:  Paediatr Child Health       Date:  2003-12       Impact factor: 2.253

5.  The Pediatric Investigators Collaborative Network on Infections in Canada: A model for multicentre research collaboration.

Authors:  E E Wang
Journal:  Paediatr Child Health       Date:  1999-09       Impact factor: 2.253

Review 6.  Bronchiolitis.

Authors:  Thomas Bourke; Michael Shields
Journal:  BMJ Clin Evid       Date:  2011-04-11

Review 7.  Health care-acquired viral respiratory diseases.

Authors:  William P Goins; H Keipp Talbot; Thomas R Talbot
Journal:  Infect Dis Clin North Am       Date:  2011-03       Impact factor: 5.982

8.  High incidence of pulmonary bacterial co-infection in children with severe respiratory syncytial virus (RSV) bronchiolitis.

Authors:  K Thorburn; S Harigopal; V Reddy; N Taylor; H K F van Saene
Journal:  Thorax       Date:  2006-03-14       Impact factor: 9.139

9.  A model of the costs of community and nosocomial pediatric respiratory syncytial virus infections in Canadian hospitals.

Authors:  Philip Jacobs; Douglas Lier; Katherine Gooch; Katharina Buesch; Michelle Lorimer; Ian Mitchell
Journal:  Can J Infect Dis Med Microbiol       Date:  2013       Impact factor: 2.471

Review 10.  Bronchiolitis.

Authors:  Juan Manuel Lozano
Journal:  BMJ Clin Evid       Date:  2007-10-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.